In addition to suppressing tumor growth in mouse cancer models, T-Dxd activated dendritic cell maturation through the upregulation of CD86 and major MHC-II expression, along with the increased expression of PD-L1 and MHC class I expression on tumor cells [183]. Here, CD86 is linked to neoplasm.